Skip to content

Experimentation of Sensorized Pseudoelastic Orthoses Produced by Additive Manufacturing

Experimentation of Sensorized Pseudoelastic Orthoses Produced by Additive Manufacturing

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04328857
Enrollment
34
Registered
2020-03-31
Start date
2020-10-01
Completion date
2023-05-31
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury

Brief summary

The proposed clinical investigation plan is a pivotal controlled study with two parallel groups, has a total duration of 12 months and involves the recruitment of 34 pediatric patients suffering from acquired brain injury. The primary objective of the clinical study is to evaluate the improvement of joint stiffness through the use of sensorized pseudoelastic orthoses for the rehabilitation of pediatric patients with acquired brain injury. The effectiveness of the treatment in terms of joint stiffness (primary outcome) will be assessed and the effect of the treatment will be quantified with clinical evaluation scales and instrumental measurements by means of an optoelectronic system and isokinetic machine. The tolerability and acceptability of the device will also be checked.

Interventions

DEVICEpseudoelastic orthosis

The subject will be given specific physiotherapy including activities oriented to multimodal exploration and refinement of gross and fine motor skills, customized according to the functional status of the individual patient.

Sponsors

CNR - ICMATE UOS di Lecco
CollaboratorUNKNOWN
IRCCS Eugenio Medea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

1. Quadriplegia or acquired hemiplegia. 2. Age 6-20 years. 3. Dystonic, dyskinetic, spastic. 4. Chronic phase patients (\> 1 year post event). 5. Spastic syndrome with Ashworth Score (AS) for the limb of interest\> 1. 6. Collaborative.

Exclusion criteria

1. Fixed limitations of the joint. 2. Joint pain. 3. Skin allergies. 4. Behavioral and psychiatric disorders (eg, emotional problems, anxiety, panic attacks).

Design outcomes

Primary

MeasureTime frameDescription
Joint Stiffness of affected upper limb jointAfter 4 weeks of treatmentQuantitative measure performed by means of an isokinetic machine (Unit of measure: Nm/°). Changes in joint stiffness following the use of new customized devices during a rehabilitation treatment period. Lower stiffness is better.

Secondary

MeasureTime frameDescription
Melbourne Upper Limb Assessment 2After 4 weeks of treatmentClinical scale for evaluating quality of upper limb movement (16 items, each assessed from 0 to 4 points). Result reported in %. Higher is better.
Quality of Upper Extremity Skills TestAfter 4 weeks of treatmentClinical scale evaluating the quality of upper extremity function (33 items, 4 domains). Minimum score 0, maximum score 100. Higher is better.
Modified Ashworth ScaleAfter 4 weeks of treatmentClinical scale for spasticity (5 levels), higher is worse.
Passive range of motionAfter 4 weeks of treatmentMeasured with goniometer in degrees.
Range of motion of target joint during a pointing-forward taskAfter 4 weeks of treatmentMeasured in degrees. A kinematic analysis will be performed during a pointing-forward task using an optoelectronic system.
Active range of motionAfter 4 weeks of treatmentMeasured with goniometer in degrees.

Countries

Italy

Contacts

Primary ContactElena Beretta
elena.beretta@lanostrafamiglia.it031877851
Backup ContactFAbio A Storm
fabio.storm@lanostrafamiglia.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026